 So, just a couple of last comments with any other questions for the panelists. We'll move on to the end game here. So, I think we're just about right on time. So, before we go, I just, I couldn't stop myself. A little advertisement for our program here. Just this spring, so it's fresh in our mind. We've launched what we call the kidney cancer multi-specialty clinic on our campus. We're newly diagnosed patients with kidney cancer is really the focus. But in a single afternoon session, you would come in and you'd meet with a medical oncologist, so primarily myself, a urologist, which would be some of the faculty we've met here today, John Gore, George Shade, and a radiation oncologist and Dr. Jing Zhang that was here this morning as also staffs this clinic. So, three different specialists to give you a comprehensive multi-modality approach to what's going to be the game plan for managing a new cancer diagnosis. And we also sit and have a conference with a pathologist that reviews any, if there's biopsy or if there was an outside surgery. And our radiologists that review the scans. And so you have expertise from five different medical specialists brought to bear in one afternoon. And then also just the scheduling assistance of a nurse navigator. So if we all get together and we say you need to have this spot and this bone are radiated, then you're going to go and have the surgeons do an effect to me and then you're going to come back and we'll talk about our systemic therapy approaches that all those appointments get scheduled to get help navigating different parts of our campus and getting it all planned out. And so I think it's going to be great for patients particularly that need to see multiple different specialists. Get that done quickly, have a game plan on the table and help to have some support to make sure you know where you're going and who you're seeing. Sort of a quarterback to guide you through the whole process. I think it's challenging when you're on your own and you have to see different specialists. Even worse when you're straddling different care networks and seeing doctors that don't really closely work with each other or have a shared medical record. So that's new on our campus and we're very excited about. And so you know I, the people here I hope many of you have certainly worked with us and are familiar with our program. But I think we do have kidney cancer assets that run in our program that are unique in Seattle and in the Northwest. This program today we anticipate being an annual event. This is our third go around and we certainly expect to do it next year and keep it going. Our multi-specialty clinic leverages the fact that we do have specialists in different areas that have great expertise specifically for kidney cancer. So our clinic launch is a unique product. You can't easily do the same thing elsewhere in Seattle. We have treatment modalities on our campus that are specific to our campus. You can't easily do elsewhere, at least not in the Seattle area. We are a referral site for interleukin 2 which is cumbersome therapy, needs some expertise to administer. Other Seattle campuses don't typically offer that. We have a clinical trials portfolio many studies of which would be unique to our campus. We occasionally overlap with other centers but most of what we're doing you couldn't easily do elsewhere. We'll have studies opening in 2017 that are studies that we've designed ourselves. And so we'll be the only place, not only in Seattle but the only place in the country where you'll be able to do certain styles of therapy. And laboratory research, a little bit of that. You saw today with Dr. George Shea talking about the histotrypsy technique he's working to develop. There are other research laboratories on campus doing things that are kidney cancer specific. We can't be comprehensive and go over every avenue in today's format but there's more going on in other places. So I hope you've enjoyed the program. I think it's a great opportunity to help you network. If you want to give us feedback on what you think would be exciting or ways that this sort of program could be changed or improved or things you'd like us to know. My phone and email contact is on the screen. It's a chance if you aren't familiar with the local Seattle kidney cancer association chapter with Art and Julie here to get on the mailing list, the emailing list and get regular updates if you're interested to participate and go to meetings. And an opportunity to hook up with our campus. I have had patients that were excited about research opportunities on our campus. Our development offices both through the university and through Fred Hutch are ambassadors. If you're interested to look under the hood and see what's going on, meet lab investigators, take a tour of the campus. We can put you in touch with folks that'd be happy to meet with you. Show you around and let you see what's going on. I have had my own patients that have actually donated money that has gone directly to kidney cancer research and I have my hand in a collaboration with a research lab looking at T cell reactivity hoping that that eventually would come forward as a T cell therapy clinical study and that is funded entirely by a donation given by one of my patients at this point in time. To truly be a therapy it's going to take money probably coming from a pharmaceutical sponsor but the preliminary work that we'd have to show is all based on foundation giving. So there are opportunities to learn more and participate on campus for people that are interested. So that all information is captured here and that is all I wanted to say for today's program. Thank you. I think Carrie may be gone. But KCA that sponsors this program and lets this go forward so certainly thankful to Carrie and help not on site but Amanda sure that also helped to facilitate things so you're still here. So thank you to KCA for sponsoring the program today. My colleagues that were speakers today I think most have had to move on. Our local chapter for KCA participating and helping to put on today's program and Samantha that was here this morning she's left but my administrative help Samantha Leppity that really was the engine that put this whole program together did a fantastic amount of work was visible here this morning getting everything set up and arranged and more ado that did the mailing times two with the wrong date the first go round but I think that was a great help this go round to get the word out and hopefully most people were in some fashion either in clinic or by mailings or on our web page were able to find out that this was happening so I thank you our patients that work with us patients from other networks families caregivers I hope you've had a good session today and mark it down for 2018 late June early July we expect to come back around and have another program so thank you very much